Article Versions Notes

Lee Y-Z, Hsu H-Y, Yang C-W, Lin Y-L, Chang S-Y, Yang R-B, Liang J-J, Chao T-L, Liao C-C, Kao H-C, et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics. 2022; 14(7):1511. https://doi.org/10.3390/pharmaceutics14071511

Lee, Yue-Zhi, Hsing-Yu Hsu, Cheng-Wei Yang, Yi-Ling Lin, Sui-Yuan Chang, Ruey-Bing Yang, Jian-Jong Liang, Tai-Ling Chao, Chun-Che Liao, Han-Chieh Kao, and et al. 2022. "The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b" Pharmaceutics 14, no. 7: 1511. https://doi.org/10.3390/pharmaceutics14071511

Lee, Y.-Z., Hsu, H.-Y., Yang, C.-W., Lin, Y.-L., Chang, S.-Y., Yang, R.-B., Liang, J.-J., Chao, T.-L., Liao, C.-C., Kao, H.-C., Chang, J.-Y., Sytwu, H.-K., Chen, C.-T., & Lee, S.-J. (2022). The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics, 14(7), 1511. https://doi.org/10.3390/pharmaceutics14071511